Community Activities - Neurocrine's drug cuts schizophrenia symptoms in mid-stage study

Published on 2024/10/04
Published by JamisonBarr
Viewed by 6 people
#4174
213.00 $

Description of item

Aug 28 (Reuters) - Neurocrine Biosciences said on Wednesday its drug helped reduce the severity of schizophrenia symptoms in a mid-stage trial, but its shares fell nearly 17% on worries whether the benefit could be replicated in larger trials.

A 20 milligram dose of the drug, the lowest, achieved a 7. Should you beloved this post as well as you desire to be given guidance about neurocaine powder for sale usa generously visit the web-page. 5 points reduction in a scale used to measure the severity of symptoms in the study that enrolled 210 patients, the company said, performing better than higher doses.

The results sparked questions over whether or not the drug, called NBI-1117568, could reproduce a similar effect buy neurocaine powder in bulk usa larger trials.

Location

Country
United States
Region
CENTRE
City
Libourne
Address
82 Rue Du Paillle En Queue

Review & feedback on Neurocrine's drug cuts schizophrenia symptoms in mid-stage study(0)

    Be first to review or feedback

    Add new review

    Post any questions you have or your experience with this item or seller. All comments are moderated
    Real name or Username
    Will not be published
    Review, feedback or question
    *
    This field is required
    Clear